ES2054935T3 - Actividad anti-vih de bu-3608. - Google Patents

Actividad anti-vih de bu-3608.

Info

Publication number
ES2054935T3
ES2054935T3 ES89112126T ES89112126T ES2054935T3 ES 2054935 T3 ES2054935 T3 ES 2054935T3 ES 89112126 T ES89112126 T ES 89112126T ES 89112126 T ES89112126 T ES 89112126T ES 2054935 T3 ES2054935 T3 ES 2054935T3
Authority
ES
Spain
Prior art keywords
susceptible
hiv
aids
infection
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89112126T
Other languages
English (en)
Inventor
Toshikazu Oki
Naoki Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2054935T3 publication Critical patent/ES2054935T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ES PRESENTADO UN METODO PARA PREVENIR INFECCION DE UNA MATERIA HUESPED VIVIENTE SUSCEPTIBLE CUANDO ESTA EN CONTACTO CON EL VIRUS DE INMUNODEFICIENCIA HUMANO (HIV) O CELULAS INFECTADAS CON EL MISMO, EL CUAL ES LA CAUSA CONOCIDA DE SIDA O PRE-SIDA. EL METODO COMPRENDE EL CONTACTO DE LA MATERIA HUESPED VIVIENTE SUSCEPTIBLE CON UNA CANTIDAD ANTIVIRICA EFECTIVA DE UN COMPUESTA BU-3608. EL USO DEL COMPUESTO BU-3608 PARA PREPARAR UNA COMPOSICION FARMACEUTICA PARA PREVENIR LA INFECCION DE UN SUSTRATO BIOLOGICO VIVIENTE SUSCEPTIBLE CON VIRUS HIV ES TAMBIEN PRESENTADO.
ES89112126T 1988-07-01 1989-07-03 Actividad anti-vih de bu-3608. Expired - Lifetime ES2054935T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21422688A 1988-07-01 1988-07-01

Publications (1)

Publication Number Publication Date
ES2054935T3 true ES2054935T3 (es) 1994-08-16

Family

ID=22798273

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89112126T Expired - Lifetime ES2054935T3 (es) 1988-07-01 1989-07-03 Actividad anti-vih de bu-3608.

Country Status (12)

Country Link
EP (1) EP0351625B1 (es)
JP (1) JP2802336B2 (es)
KR (1) KR0131323B1 (es)
AT (1) ATE87827T1 (es)
CA (1) CA1335078C (es)
CY (1) CY1847A (es)
DE (1) DE68905875T2 (es)
ES (1) ES2054935T3 (es)
GR (1) GR3007580T3 (es)
HK (1) HK110095A (es)
IL (1) IL90783A (es)
ZA (1) ZA894984B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338728A (en) * 1992-08-14 1994-08-16 Bristol-Myers Squibb Pradimicin compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870165A (en) * 1987-02-02 1989-09-26 Bristol-Myers Company Antifungal antibiotics

Also Published As

Publication number Publication date
CY1847A (en) 1996-03-08
JP2802336B2 (ja) 1998-09-24
ZA894984B (en) 1990-03-28
DE68905875T2 (de) 1993-07-15
DE68905875D1 (de) 1993-05-13
EP0351625B1 (en) 1993-04-07
JPH0248530A (ja) 1990-02-19
KR900001374A (ko) 1990-02-27
EP0351625A1 (en) 1990-01-24
HK110095A (en) 1995-07-14
CA1335078C (en) 1995-04-04
ATE87827T1 (de) 1993-04-15
IL90783A0 (en) 1990-01-18
IL90783A (en) 1994-01-25
GR3007580T3 (es) 1993-08-31
KR0131323B1 (ko) 1998-04-17

Similar Documents

Publication Publication Date Title
CA2072573A1 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
ATE133449T1 (de) Infektiöses system zur arzneimittelabgabe
DK92788A (da) Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
DK524788D0 (da) Anvendelse af morphin-antagonister til fremstilling af laegemidler med immunomodulerende og antiviral effekt, isaer til behandling af erhvervede immundefekt-tilstande
DE3780016D1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin-2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
EP0403251A3 (en) Monokine activity interference
DE68906735D1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
BR9105902A (pt) Novo polipeptídeo
EP0323157A3 (en) Antiviral compounds and methods
WO1990013281A3 (en) Method of suppressing hiv infection
ES2054935T3 (es) Actividad anti-vih de bu-3608.
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
EP0311108A3 (en) Anti-hiv active 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
DK135588A (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
DE68929084D1 (de) Arzneimittel zur Verhinderung einer Infektion mit dem für AIDS verantwortlichen Virus
UA6149A1 (uk) 2-(2'7'-діацетоксіфлуореніліден-9'-гідразоно)-5-(п-нітробензіліден)-тіазолідон-4,що виявляє противірусну дію щодо віруса грипу а та а-2, а також віруса осповакцини
UA7930A1 (uk) 2-(2,7-діацетоксіфлуорениліден-9-гідразоно)-5-фурфурилідентіазолідон-4, що виявляє противірусну дію відносно віруса венесуельського енцефаліту коней та віруса грипа типу а та а-2
ATE67674T1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.
JPS6471815A (en) Antiviral composition containing 5-amino-2- (4-methylpiperidine-1-yl)phenyl-4- chlorophenylmethanone
SU1797350A1 (ru) Способ обнаружения вируса иммунодефицита человека

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351625

Country of ref document: ES